Ex-Palantir Engineers Raise $600M to Disrupt US Health Insurers

Angle Health, a health benefits platform founded by former Palantir Technologies engineers, has secured $600 million in funding at a valuation of $2.7 billion. The round was led by Vitruvian Partners, a London-based growth investor with a significant footprint in European technology exits. This capital injection arrives as US employers confront the sharpest increase in healthcare premiums in two decades, creating an urgent market for cost-containment solutions.

“We did not set out to build another health insurance company,” said Ty Wang, co-founder and chief executive of Angle Health. The aim, he told the Wall Street Journal, was to stop “this kind of death spiral of cost within our healthcare system.”

The financing structure reveals more than just new capital entering the business. The $600 million total comprises a $200 million Series C and a $400 million tender offer. The secondary portion allows existing shareholders to cash out rather than injecting fresh funds into the company’s operations. While the company announces a unified $2.7 billion valuation, the Wall Street Journal reported that the secondary transaction priced the firm at $2.5 billion. This discrepancy highlights that the headline figure primarily reflects the value of the new equity issuance rather than the price paid by investors transferring shares among themselves.

From Palantir to Small Business Coverage

Wang and Chief Technology Officer Anirban Gangopadhyay established the company in 2019, launching its services in 2021. The duo met as high school students through the Stokes Educational Scholarship programme, a government initiative designed to prepare students for careers in national security. They later collaborated at Palantir before founding Angle Health to address a specific inequity in the American benefits landscape.

“Access to great healthcare shouldn’t depend on the size of the company you work for,” Wang said in the announcement.

The platform targets small businesses, which employ nearly half of the US workforce but often lack the bargaining power of large corporations. Angle Health currently serves over 5,000 employers across 47 states, including firms with as few as two employees. The product is described as the first AI-native healthcare benefits platform, combining underwriting capabilities with a digital benefits interface. Brokers utilize a tool called Benefit Builder to generate quotes in minutes based on staff census data, allowing for real-time plan adjustments.

The AI engine is designed to steer patients toward lower-cost care settings without compromising quality. Examples include directing users to at-home infusion centers, free-standing imaging facilities, and international prescription sourcing. Jeremy Gelber, the Vitruvian partner who led the investment, emphasized the scalability of this approach.

“Because of AI, they’re able to manage thousands of different designs,” Gelber said.

Supporting tools such as Quote-to-Card handle implementation logistics, while a proprietary Health Scorecard rates plans, a feature the company claims is unique in group underwriting. Additionally, Angle Health has formed partnerships with care delivery providers specializing in high-cost medications, infusions, outpatient surgery, and radiology.

Financial Claims and Market Context

Angle Health reports robust growth metrics, citing 120% year-on-year expansion and four consecutive quarters of profitability on both EBITDA and net income bases. The company oversees approximately $1 billion in annualized premium equivalents. According to the Wall Street Journal, both customer count and revenue more than doubled in the most recent fiscal year.

The company positions its value proposition around renewal pricing stability. It claims median increases for its clients range between 5% and 7%. In contrast, a June 2026 study by Morgan Health, a unit of JPMorgan Chase, found that small and midsize businesses face median premium hikes of 18%. Consulting firm WTW projects that US employer healthcare costs will rise by 11.1% in 2027, marking the steepest increase in over twenty years.

It is important to note that these figures are self-reported. No independent audit has verified the profitability claims or the specific savings percentages attributed to the platform. For a firm assuming insurance risk, such statements represent internal projections rather than audited facts.

European Capital Meets US Healthcare

The significance of this deal extends beyond the United States due to the profile of its lead investor. Vitruvian Partners manages over $23 billion in active funds from offices in London, Munich, Madrid, Stockholm, and Luxembourg. Its portfolio includes notable European unicorns such as Skyscanner, Just Eat, Wise, Darktrace, Global-e, and EasyPark. The firm also previously backed Hinge Health, giving it experience in the American employer-benefits sector.

European growth funds have been raising larger vehicles recently, and this transaction represents a major deployment of that capital into US healthcare. Other participants in the round included Town Hall Ventures, co-founded by Andy Slavitt, who held senior health policy roles during the Obama and Biden administrations. Existing backers Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator also participated. Portage had led a $134 million round in December, and the new valuation more than doubles that previous mark.

The deal is expected to close later this month. While European insurtech has produced several unicorns this year, none have yet reached this scale in the health coverage space, marking a significant milestone for cross-Atlantic investment in healthcare infrastructure.